Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for Temozolomide (DB00853)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02871843RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic GliomasTreatment